Tatiana Fofanova is the CEO of Koda Health. She is dealing with one of the most difficult parts of health care. How do you get patients wishes in the case of end of life or other critical illness made in advance and delivered to medical professionals? Koda Health has not only figured out how to…
Con el verano marcando el comienzo de la temporada alta de mosquitos, autoridades sanitarias y de control de vectores se preparan para la posibilidad de otro año con tasas históricas de dengue. Y con el cambio climático, la falta de una vacuna eficaz y los recortes federales en la investigación, les preocupa que la enfermedad…
Cuando Pam McClure se enteró que el próximo año ahorraría casi $4,000 en sus medicamentos recetados dijo: “parece demasiado bueno para ser verdad”. Para finales de 2024, habrá gastado casi $6,000 en estos fármacos, incluido uno para controlar su diabetes. McClure, de 70 años, es una de las aproximadamente 3.2 millones de personas con un…
Prioritizing risk-based management, data science, smart automation, standards, and patient optionality are critical for the industry to keep up with market changes. The recent FDA guidance that encourages ‘pragmatic trials’ in specific scenarios is a move in the right direction. The post Carving a Path Toward Pragmatic Innovation in Clinical Trials appeared first on MedCity…
By AMI PAREKH A little-noticed telehealth safe harbor provision tucked inside the One Big Beautiful Bill was a significant milestone in virtual care. Though it specifically addresses pre-deductible telehealth services in high-deductible health plans, the legislation has far wider implications for both care delivery and insurance design, especially in the commercial insurance market. In fact…
From an interesting review paper in the Journal of Economic Perspectives by Craig Garthwaite: Although research and development investments clearly respond to market opportunities, the exact benefits created by these incremental investments remain unclear. This is largely because the exact marginal products developed in response to these incentives are elusive to identify. Certainly, the amount…
Providers don’t need to endorse ibogaine treatment to take this moment seriously. They need to understand it, respect the risk, and prepare for those already seeking it. The post Ibogaine and SUD Treatment: Signal, Risk, and the Role of Providers appeared first on MedCity News.
By MIKE MAGEE The Ghost of Christmas Past, in the form of Surgeon General C. Everett Koop, has returned this season to torture one RFK Jr who refuses to fully share life saving vaccines with children. In the encounter, the ghostly Koop reviews a time 37 years ago when citizens came together to celebrate separating…
Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty over how the president-elect will reconcile starkly different philosophies among the leaders of his team. Trump has promised he would allow Robert F. Kennedy Jr. to “go wild” on medicines, food, and health. With that, a…
The best healthcare technology emerges from collaborative efforts. Here’s why working alongside physicians, nurses, and home health caregivers builds a stronger foundation. The post Centering Caregiver and Provider Feedback in Home-Based Care Innovation appeared first on MedCity News.